Action Orgenesis - ORGS

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

2,11

Prix Achat

2,02

Prix Vente

2,20

Volume échangé

0,00 Fourchette du Jour 0,00

1,9283 Plage de 52 semaines 10,799

Cap du marché

10,907M

Clôture Veille

2,11

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

5 169 248

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,20

Bénéfice par action (BPA)

-10,71

Chiffre d'affairess

530k

Bénéfice net

-55,36M

Orgenesis Inc is a global biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant producti... Orgenesis Inc is a global biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). Its geographical segments include Korea, United Arab Emirates, China, India, and Greece. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

orgenesis.com

Siège social

Carson City, Nevada, USA

Fondé

Orgenesis Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ORGS. Le dernier cours de clôture d'Orgenesis était de US$2,11. Au cours de la dernière année, les actions de Orgenesis ont été négociées dans une fourchette de prix de US$ 1,9283 à US$ 10,799.

Orgenesis compte actuellement 5 169 248 actions en circulation. La capitalisation boursière d'Orgenesis est de US$10,91 million. Orgenesis a un ratio cours/bénéfice (ratio PE) de -0.20.

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia

Orgenesis’ CD19 CAR-T therapy, ORG-101, had a complete response (CR) of 82% in adults and 93% in pediatric patients with the incidence of severe Cytokine Release Syndrome (CRS) of 2% in adult...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	2.11	2.11	2.11	0	0	CS
4	0	0	2.11	2.11	2.11	0	0	CS
12	0	0	2.11	2.11	2.11	0	0	CS
26	-4.29	-67.03125	6.4	10.799	1.9283	73063	6.9261047	CS
52	-1.29	-37.9411764706	3.4	10.799	1.9283	126353	5.95476525	CS
156	-27.09	-92.7739726027	29.2	40.4	1.9283	86012	9.63083462	CS
260	-47.89	-95.78	50	120	1.9283	108112	33.30942759	CS

ORGS - Frequently Asked Questions (FAQ)

What is the current Orgenesis share price?

The current share price of Orgenesis is US$ 2,11

How many Orgenesis shares are in issue?

Orgenesis has 5 169 248 shares in issue

What is the market cap of Orgenesis?

The market capitalisation of Orgenesis is USD 10,91M

What is the 1 year trading range for Orgenesis share price?

Orgenesis has traded in the range of US$ 1,9283 to US$ 10,799 during the past year

What is the PE ratio of Orgenesis?

The price to earnings ratio of Orgenesis is -0,2

What is the cash to sales ratio of Orgenesis?

The cash to sales ratio of Orgenesis is 20,59

What is the reporting currency for Orgenesis?

Orgenesis reports financial results in USD

What is the latest annual turnover for Orgenesis?

The latest annual turnover of Orgenesis is USD 530k

What is the latest annual profit for Orgenesis?

The latest annual profit of Orgenesis is USD -55,36M

What is the registered address of Orgenesis?

The registered address for Orgenesis is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701

What is the Orgenesis website address?

The website address for Orgenesis is orgenesis.com

Which industry sector does Orgenesis operate in?

Orgenesis operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
REBNReborn Coffee Inc	US$ 3,31 (63,05%)	55,54M
FCUVFocus Universal Inc	US$ 5,87 (56,62%)	1,73M
SOPASociety Pass Inc	US$ 1,54 (56,50%)	13,82M
CYCNCyclerion Therapeutics Inc	US$ 3,92 (54,33%)	82,39M
ENVBEnveric Biosciences Inc	US$ 2,0899 (-46,41%)	1,57M
NIVFNewGenIvf Group Ltd	US$ 0,1489 (-42,51%)	14,8M
GLSTGlobal Star Acquisition Inc	US$ 8,83 (-39,10%)	23,89k
PRPHProPhase Labs Inc	US$ 0,2633 (-38,02%)	872,46k
SPGCSacks Parente Golf Inc	US$ 0,5601 (-37,86%)	7,27M
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
NVDANVIDIA Corporation	US$ 120,07 (-3,67%)	388,54M
RIMEAlgorhythm Holdings Inc	US$ 0,02565 (5,12%)	338,75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0355 (-11,25%)	236,29M
CLEUChina Liberal Education Holdings Ltd	US$ 0,1938 (30,77%)	234,8M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Orgenesis Inc (ORGS) Cours

Orgenesis Inc (ORGS)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Orgenesis Inc

ORGS Dernières nouvelles

ORGS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités